Fortis Healthcare Limited — Updates, 07-02-2025: Press Release

Consolidated revenues for Fortis Healthcare saw a robust growth of 14.8% year-on-year, reaching INR 1,928 Cr in Q3 FY25. Operating EBITDA surged by 32.0%, hitting INR 375 Cr with a margin of 19.4%, compared to 16.9% in Q3 FY24. The hospital segment contributed significantly, with revenues increasing by 16.8% to INR 1,623 Cr and an operating EBITDA margin of 20.0%. Additionally, the company has successfully consolidated its stake in Agilus Diagnostics Limited from 57.68% to 89.20%, enhancing its foothold in the diagnostics sector.

In terms of operational efficiency, the hospital business reported a notable increase in average revenue per occupied bed (ARPOB) to INR 2.45 Cr per annum, up 9.9% YoY, with overall occupancy rising to 67%. Digital revenue channels experienced healthy growth of 36.2%. Despite some challenges in the diagnostics unit, including rebranding expenses, the segment reported a strong operating margin of 14.4%. The company’s outlook remains positive, driven by strategic consolidation, increasing patient volumes, and improved operational margins.